Oppenheimer Maintains Outperform on Amgen, Raises Price Target to $450

Benzinga · 1d ago
Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $400 to $450.